Top

Journal of Neurology

Published in:

01-11-2016 | Letter to the Editors

‘De novo’ Col4A2 mutation in a patient with migraine, leukoencephalopathy, and small carotid aneurysms

Authors: Paul Kollmann, André Peeters, Olivier Vanakker, Yves Sznajer

Published in: Journal of Neurology | Issue 11/2016

Excerpt

Dear Sirs, …

Murray LS, Lu Y, Taggart A et al (2014) Chemical chaperone treatment reduces intracellular accumulation of mutant collagen IV and ameliorates the cellular phenotype of a COL4A2 mutation that causes haemorrhagic stroke. Hum Mol Genet 23(2):283–292. doi:10.1093/hmg/ddt418 CrossRefPubMed

Vilain C, Van Regenmorter N, Verloes A et al (2002) Neuroimaging fails to identify asymptomatic carriers of familial porencephaly. Am J Med Genet 112(2):198–202. doi:10.1002/ajmg.10452 CrossRefPubMed

Jeanne M, Labelle-Dumais C, Jorgensen J et al (2012) COL4A2 mutations impair COL4A1 and COL4A2 secretion and cause hemorrhagic stroke. Am J Hum Genet 90(1):91–101. doi:10.1016/j.ajhg.2011.11.022 CrossRefPubMedPubMedCentral

Jeanne M, Jorgensen J, Gould DB (2015) Molecular and genetic analyses of collagen type IV Mutant mouse models of spontaneous intracerebral hemorrhage identify mechanisms for stroke prevention. Circulation 131(18):1555–1565. doi:10.1161/CIRCULATIONAHA.114.013395 CrossRefPubMedPubMedCentral

Plaisier E, Gribouval O, Alamowitch S et al (2007) COL4A1 mutations and hereditary angiopathy, nephropathy, aneurysms, and muscle cramps. N Eng J Med 357:2687. doi:10.1056/NEJMoa071906 CrossRef

Kuo DS, Labelle-Dumais C, Gould DB (2012) COL4A1 and COL4A2 mutations and disease: insights into pathogenic mechanisms and potential therapeutic targets. Hum Mol Genet 21(R1):R97–R110. doi:10.1093/hmg/dds346 CrossRefPubMedPubMedCentral

Yoneda Y, Haginoya K, Arai H et al (2012) De novo and inherited mutations in COL4A2, encoding the type IV collagen α2 chain cause porencephaly. Am J Hum Genet 90(1):86–90. doi:10.1016/j.ajhg.2011.11.016 CrossRefPubMedPubMedCentral

Gunda B, Mine M, Kovács T et al (2014) COL4A2 mutation causing adult onset recurrent intracerebral hemorrhage and leukoencephalopathy. J Neurol 261(3):500–503. doi:10.1007/s00415-013-7224-4 CrossRefPubMed

Verbeek E, Meuwissen ME, Verheijen FW et al (2012) COL4A2 mutation associated with familial porencephaly and small-vessel disease. Eur J Hum Genet 20(8):844–851. doi:10.1038/ejhg.2012.20 CrossRefPubMedPubMedCentral

10.

Vahedi K, Alamowitch S (2011) Clinical spectrum of type IV collagen (COL4A1) mutations: a novel genetic multisystem disease. Curr Opin Neurol 24(1):63–68. doi:10.1097/WCO.0b013e32834232c6 CrossRefPubMed

11.

Corlobe A, Tournier-Lasserve E, Mine M et al (2013) COL4A1 mutation revealed by an isolated brain hemorrhage. Cerebrovasc Dis 35(6):593–594. doi:10.1159/000351520 CrossRefPubMed

Title: ‘De novo’ Col4A2 mutation in a patient with migraine, leukoencephalopathy, and small carotid aneurysms
Authors: Paul Kollmann
André Peeters
Olivier Vanakker
Yves Sznajer
Publication date: 01-11-2016
Publisher: Springer Berlin Heidelberg
Published in: Journal of Neurology / Issue 11/2016
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-016-8280-3

At a glance: The STEP trials

Springer Medicine

‘De novo’ Col4A2 mutation in a patient with migraine, leukoencephalopathy, and small carotid aneurysms

Excerpt

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 11/2016

Ice bucket challenge bears fruit for amyotrophic lateral sclerosis

Spinocerebellar ataxia type 3 in Israel: phenotype and genotype of a Jew Yemenite subpopulation

Hearing and dementia

Łucja Frey (1889–1942)

An early case of a natural barrier to axonal degeneration

Severe axonal neuropathy is a late manifestation of SPG11